1.The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF.
Jung Hwan KIM ; Jae Chan KIM ; Seung Hwan SHIN ; Soo Ik CHANG ; Hyo Sil LEE ; Soo Il CHUNG
Experimental & Molecular Medicine 1999;31(4):203-209
Angiostatin is a potent angiogenesis inhibitor that is composed of the first four kringles of plasminogen fragment. Angiostatin with one less kringle molecule (kringle 1 to 3) was recently demonstrated to be an effective angiogenic inhibitor. To determine whether recombinant plasminogen kringle 1-3 (rPK1-3) can inhibit the corneal neovascularization induced by potent angiogenic factors; angiogenin, bFGF, or VEGF, hydron polymer discs each containing 2.0 microg of angiogenin, 500 ng of bFGF, or 500 ng of VEGF respectively were implanted into the corneal stroma of 138 rabbit eyes, and then discs each containing 10 microg, 12.5 microg, 20 microg or 30 microg of rPK1-3 were implanted randomly. Discs containing phosphate buffered saline were also implanted as a control. The angiogenesis score on number and length of newly formed vessels on the each of the rabbit's cornea were recorded daily by two observers (blinded). The treated corneas were also examined histologically. Recombinant PK1-3 treated corneas showed less neovascularization induced by all angiogenic factors (p < 0.05). and the extent of inhibition of neovascularization was proportional to the concentration of rPK1-3 (p < 0.05). Histologic examination showed leukocyte infiltration into the corneal stroma on the PBS treated eyes whereas rPK1-3 treated eyes showed only traces of leukocytes. These results of the effective rPK1-3 inhibition of corneal neovascularization induced by angiogenin, bFGF, or VEGF suggest that this angiostatin related fragment, rPK1-3, may be useful in the treatment of various neovascular diseases. Copyright 2000 Academic Press.
Angiogenesis Inhibitors/pharmacology*
;
Angiogenesis Inhibitors/genetics
;
Animal
;
Chick Embryo
;
Chorion/drug effects
;
Chorion/blood supply
;
Cornea/pathology
;
Cornea/drug effects
;
Cornea/blood supply*
;
Endothelial Growth Factors/pharmacology
;
Fibroblast Growth Factor, Basic/pharmacology
;
Kringles/genetics
;
Lymphokines/pharmacology
;
Microscopy/methods
;
Neovascularization, Pathologic/drug therapy*
;
Plasminogen/pharmacology*
;
Plasminogen/genetics*
;
Rabbits
;
Recombinant Proteins/pharmacology
;
Recombinant Proteins/genetics
;
Ribonuclease, Pancreatic/pharmacology
2.Angiogenesis effects of nerve growth factor (NGF) on rat corneas.
Kangmoon SEO ; Jongil CHOI ; Myungjin PARK ; Changhun RHEE
Journal of Veterinary Science 2001;2(2):125-130
This study was performed to evaluate the effects of nerve growth factor (NGF) upon angiogenesis in the rat cornea, to examine its possible application as an alternative angiogenic inducer and to provide basic data for further studies. Angiogenesis was induced by cornea micropocket assay, as previously described. Eight of thirty two eyes of Sprague-Dawley rats were randomly assigned to one of four groups, namely, a non-NGF group (Group 0), a 0.5 ng of NGF group (Group 0.5), a 1.0 ng of NGF group (Group 1.0) and a 5.0 ng of NGF group (Group 5.0). Pellets made of poly-2-hydroxylethylmethacrylate and sucralfate were implanted into the corneal stroma no closer than 1 mm from the limbus. After the implantation, the number of new vessels, vessel length and circumferential neovascularization were examined daily under the surgical microscope over a period of 7 days. The area of neovascularization was determined using a mathematical formula. Although new vessels in Group 0 and Group 0.5 were first observed at day 5, those of Groups 1.0 and 5.0 were first noted on days 4 and 3, respectively. However, the growth rates of new vessels in Groups 1.0 and 5.0 were higher than those of Groups 0 and 0.5 with the passage of time. The number, length, circumferential neovascularization and areas covered by the vessels in Groups 1.0 and 5.0 were significantly more than in Group 0 and Group 0.5 (p<0.05). This study showed that NGF had a dose-dependent angiogenic effects on the rat cornea and that the minimal effective dose of NGF was 1.0 ng per cornea. Also, it showed that NGF would be useful in angiogenic studies as an alternative angiogenic inducer.
Angiogenesis Inducing Agents/*toxicity
;
Animals
;
Cornea/blood supply/*drug effects
;
Corneal Neovascularization/*chemically induced
;
Dose-Response Relationship, Drug
;
Female
;
Male
;
Nerve Growth Factor/*toxicity
;
Random Allocation
;
Rats
;
Rats, Sprague-Dawley